HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Werner Seeger Selected Research

dironyl (terguride)

1/20155-HT2B receptor antagonists inhibit fibrosis and protect from RV heart failure.
11/2010Increased expression of 5-hydroxytryptamine2A/B receptors in idiopathic pulmonary fibrosis: a rationale for therapeutic intervention.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Werner Seeger Research Topics

Disease

69Pulmonary Hypertension (Ayerza Syndrome)
01/2016 - 01/2002
54Anoxia (Hypoxia)
01/2015 - 01/2002
27Fibrosis (Cirrhosis)
10/2015 - 09/2002
17Neoplasms (Cancer)
02/2015 - 03/2004
16Adult Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2015 - 12/2003
14Idiopathic Pulmonary Fibrosis
11/2015 - 01/2008
14Inflammation
01/2015 - 06/2002
12Pulmonary Fibrosis (Hamman Rich Syndrome)
10/2015 - 12/2003
12Lung Injury
05/2015 - 01/2004
12Acute Lung Injury
01/2014 - 02/2007
10Pneumonia (Pneumonitis)
01/2015 - 03/2004
9Cardiomegaly (Heart Hypertrophy)
11/2014 - 01/2004
8Edema
01/2016 - 03/2003
8Interstitial Lung Diseases (Interstitial Lung Disease)
10/2015 - 07/2002
8Sepsis (Septicemia)
07/2014 - 06/2002
7Lung Diseases (Lung Disease)
11/2015 - 09/2004
7Infection
07/2015 - 02/2005
6Bronchopulmonary Dysplasia
06/2015 - 02/2007
6Hypertrophy
02/2014 - 08/2007
5Heart Failure
11/2015 - 01/2004
5Hyperoxia
06/2015 - 02/2007
5Lung Neoplasms (Lung Cancer)
01/2015 - 01/2009
5Right Ventricular Hypertrophy
01/2015 - 01/2010
5Dyspnea (Shortness of Breath)
10/2014 - 08/2002
5Body Weight (Weight, Body)
06/2012 - 12/2003
5Ischemia
03/2009 - 03/2003
4Emphysema
01/2015 - 10/2011
4Chronic Obstructive Pulmonary Disease (COPD)
01/2015 - 10/2008
4Sleep Apnea Syndromes (Sleep Apnea)
02/2014 - 01/2004
4Hyperplasia
12/2012 - 01/2008
4Acidosis
01/2012 - 04/2006
4Hypercapnia
01/2012 - 02/2008
4Pulmonary Heart Disease (Cor Pulmonale)
10/2008 - 01/2004
3Vascular Diseases (Vascular Disease)
11/2015 - 10/2005
3Neoplasm Metastasis (Metastasis)
02/2015 - 03/2010
3Critical Illness (Critically Ill)
01/2014 - 01/2010
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2013 - 10/2009
3Septic Shock (Toxic Shock Syndrome)
04/2006 - 03/2003
3Wegener Granulomatosis (Wegener's Granulomatosis)
10/2005 - 03/2002

Drug/Important Bio-Agent (IBA)

25Idiopathic pulmonary hypertensionIBA
01/2016 - 04/2002
20MonocrotalineIBA
07/2014 - 01/2004
17Bleomycin (Blenoxane)FDA LinkGeneric
10/2015 - 12/2003
16Iloprost (Ventavis)FDA Link
03/2015 - 01/2002
14sildenafil (Viagra)FDA Link
06/2015 - 04/2002
14OxygenIBA
03/2013 - 01/2002
11CollagenIBA
11/2015 - 12/2003
11Epoprostenol (Prostacyclin)FDA LinkGeneric
10/2011 - 04/2002
10CytokinesIBA
02/2013 - 06/2002
9Messenger RNA (mRNA)IBA
01/2015 - 03/2002
9Transcription Factors (Transcription Factor)IBA
11/2014 - 10/2002
8EmulsionsIBA
01/2015 - 09/2003
8Carbon MonoxideIBA
10/2014 - 03/2003
8Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2013 - 09/2002
7Small Interfering RNA (siRNA)IBA
01/2015 - 05/2005
7NADPH Oxidase (NAD(P)H oxidase)IBA
02/2014 - 05/2004
715-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidIBA
01/2011 - 12/2003
6glucuronyl glucosamine glycan sulfate (Vessel)IBA
02/2015 - 10/2005
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2014 - 06/2002
6NADP (NADPH)IBA
03/2012 - 01/2005
6OxidoreductasesIBA
03/2012 - 01/2005
6treprostinilFDA Link
10/2011 - 04/2006
6Arachidonic Acid (Vitamin F)IBA
03/2009 - 05/2002
5Guanylate Cyclase (Guanylyl Cyclase)IBA
01/2015 - 01/2006
5Reactive Oxygen Species (Oxygen Radicals)IBA
02/2014 - 12/2003
5Superoxides (Superoxide)IBA
12/2013 - 12/2003
5imatinib (Gleevec)FDA Link
01/2013 - 10/2005
5FibrinIBA
12/2008 - 07/2002
5ProstaglandinsIBA
03/2008 - 07/2003
5Pulmonary Surfactants (Pulmonary Surfactant)IBA
07/2007 - 01/2004
4Adenosine Triphosphatases (ATPase)IBA
01/2016 - 10/2005
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2015 - 01/2002
4EnzymesIBA
06/2015 - 01/2008
4Hydroxyproline (4 Hydroxyproline)IBA
05/2015 - 12/2003
4Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2015 - 03/2008
4Soybean OilFDA LinkGeneric
01/2015 - 05/2002
4SmokeIBA
01/2015 - 10/2011
4indium-bleomycinIBA
01/2013 - 03/2004
4Matrix MetalloproteinasesIBA
01/2013 - 09/2009
4Transforming Growth Factors (Transforming Growth Factor)IBA
12/2009 - 02/2007
3Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
11/2015 - 09/2008
3Biological Markers (Surrogate Marker)IBA
11/2015 - 04/2008
3Chymases (Chymase)IBA
10/2015 - 06/2013
3Protein CIBA
07/2015 - 08/2004
3Carrier Proteins (Binding Protein)IBA
01/2015 - 10/2008
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2015 - 01/2011
3Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
01/2015 - 01/2010
3Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
03/2014 - 09/2009
3Phosphotransferases (Kinase)IBA
02/2013 - 04/2011
3Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
06/2012 - 10/2005
3AntibodiesIBA
06/2010 - 06/2002
3Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
03/2010 - 12/2003
3Transforming Growth Factor beta (TGF-beta)IBA
12/2009 - 02/2007
3Arginine (L-Arginine)FDA Link
11/2009 - 01/2008
3EicosanoidsIBA
03/2009 - 05/2002
3ExotoxinsIBA
05/2008 - 10/2002
3Angiotensin IIIBA
12/2007 - 05/2005

Therapy/Procedure

6Parenteral Nutrition
01/2015 - 05/2003
4Transplants (Transplant)
05/2011 - 02/2004
3Immunomodulation
01/2015 - 02/2007
3Lasers (Laser)
01/2015 - 01/2005